Maite
Herráiz Bayod
Consultora Médica
Dana–Farber Cancer Institute
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Dana–Farber Cancer Institute (1)
2022
-
Mutational signature profiling classifies subtypes of clinically different mismatch-repair-deficient tumours with a differential immunogenic response potential
British Journal of Cancer, Vol. 126, Núm. 11, pp. 1595-1603